跳到正文

Gibson Christopher 内部人交易：近期 SEC Form 4 交易

过去 18 个月，Gibson Christopher（CIK 1856369）在 2 家公司共报告 62 笔 SEC Form 4 内部人交易（最近一笔 2026-06-05）。

日期公司身份类型股数市值
2026-06-05RECURSION PHARMACEUTICALS, INC. (RXRX)董事买入40,000$0
2026-06-05RECURSION PHARMACEUTICALS, INC. (RXRX)董事卖出40,000$144,800
2026-05-27RECURSION PHARMACEUTICALS, INC. (RXRX)董事买入40,000$0
2026-05-27RECURSION PHARMACEUTICALS, INC. (RXRX)董事卖出40,000$123,200
2026-05-19RECURSION PHARMACEUTICALS, INC. (RXRX)董事卖出22,821$69,376
2026-05-08RECURSION PHARMACEUTICALS, INC. (RXRX)董事买入60,000$0
2026-05-08RECURSION PHARMACEUTICALS, INC. (RXRX)董事卖出40,000$134,800
2026-05-08RECURSION PHARMACEUTICALS, INC. (RXRX)董事卖出20,000$0
2026-04-24RECURSION PHARMACEUTICALS, INC. (RXRX)董事买入40,000$0
2026-04-24RECURSION PHARMACEUTICALS, INC. (RXRX)董事卖出40,000$144,400
2026-04-10PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)董事买入57,473$0
2026-04-08RECURSION PHARMACEUTICALS, INC. (RXRX)董事卖出40,000$124,000
2026-04-08RECURSION PHARMACEUTICALS, INC. (RXRX)董事买入40,000$0
2026-03-25RECURSION PHARMACEUTICALS, INC. (RXRX)董事买入40,000$0
2026-03-25RECURSION PHARMACEUTICALS, INC. (RXRX)董事卖出40,000$130,000
2026-03-11RECURSION PHARMACEUTICALS, INC. (RXRX)董事买入20,000$0
2026-03-11RECURSION PHARMACEUTICALS, INC. (RXRX)董事卖出20,000$0
2026-03-05PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)董事买入53,913$0
2026-02-19RECURSION PHARMACEUTICALS, INC. (RXRX)董事卖出27,265$95,155
2026-02-19RECURSION PHARMACEUTICALS, INC. (RXRX)董事买入40,000$0
2026-02-19RECURSION PHARMACEUTICALS, INC. (RXRX)董事卖出40,000$138,400
2026-02-06RECURSION PHARMACEUTICALS, INC. (RXRX)董事卖出10,364$36,896
2026-02-06RECURSION PHARMACEUTICALS, INC. (RXRX)董事买入40,000$0
2026-02-06RECURSION PHARMACEUTICALS, INC. (RXRX)董事卖出40,000$164,800
2026-02-06RECURSION PHARMACEUTICALS, INC. (RXRX)董事买入30,346$0

来源：SEC Form 4 申报文件 · 截至 2026-06-05